Representative Julie Johnson (D-Texas) recently sold shares of Solventum Co. NYSE: SOLV. In a filing disclosed on February 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Solventum stock on January 15th. The trade occurred in the Representative's "MERRILL LYNCH TAX EFFICIENT CORE" account.
Representative Julie Johnson also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Dell Technologies NYSE: DELL on 1/28/2025.
- Sold $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 1/28/2025.
- Sold $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 1/28/2025.
- Sold $1,001 - $15,000 in shares of ALLETE NYSE: ALE on 1/28/2025.
- Sold $1,001 - $15,000 in shares of PPG Industries NYSE: PPG on 1/27/2025.
- Purchased $1,001 - $15,000 in shares of Progressive NYSE: PGR on 1/24/2025.
- Purchased $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 1/24/2025.
- Sold $1,001 - $15,000 in shares of Chubb NYSE: CB on 1/24/2025.
- Sold $1,001 - $15,000 in shares of Morgan Stanley NYSE: MS on 1/24/2025.
- Purchased $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 1/17/2025.
Solventum Stock Down 0.4 %
Shares of SOLV traded down $0.28 during trading hours on Monday, hitting $74.04. 1,081,408 shares of the company were exchanged, compared to its average volume of 875,989. The firm's 50 day moving average is $70.75 and its 200-day moving average is $68.65. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.
Hedge Funds Weigh In On Solventum
Several large investors have recently added to or reduced their stakes in SOLV. Norges Bank acquired a new position in Solventum in the 4th quarter valued at approximately $203,740,000. Hotchkis & Wiley Capital Management LLC acquired a new position in Solventum in the 3rd quarter valued at approximately $125,488,000. Trian Fund Management L.P. raised its holdings in Solventum by 32.9% in the 3rd quarter. Trian Fund Management L.P. now owns 7,126,255 shares of the company's stock valued at $496,842,000 after acquiring an additional 1,765,676 shares in the last quarter. Boston Partners acquired a new position in Solventum in the 4th quarter valued at approximately $110,378,000. Finally, Independent Franchise Partners LLP raised its holdings in Solventum by 105.0% in the 4th quarter. Independent Franchise Partners LLP now owns 1,603,154 shares of the company's stock valued at $105,904,000 after acquiring an additional 821,272 shares in the last quarter.
Analysts Set New Price Targets
Several research firms have recently issued reports on SOLV. Morgan Stanley upped their price target on Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a research note on Monday, November 11th. Mizuho began coverage on Solventum in a research report on Wednesday, December 4th. They set a "neutral" rating and a $70.00 price objective for the company. Finally, Piper Sandler boosted their price objective on Solventum from $71.00 to $75.00 and gave the stock a "neutral" rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $68.29.
Check Out Our Latest Analysis on Solventum
About Representative Johnson
Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.
Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024.
Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.
Solventum Company Profile
(
Get Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
See Also
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
